Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.
DuCote TJ, Song X, Naughton KJ, Chen F, Plaugher DR, Childress AR, Gellert AR, Skaggs EM, Qu X, Liu J, Liu J, Li F, Wong KK, Brainson CF. DuCote TJ, et al. Among authors: brainson cf. Cancer Res Commun. 2024 Feb 13;4(2):388-403. doi: 10.1158/2767-9764.CRC-23-0399. Cancer Res Commun. 2024. PMID: 38265267 Free PMC article.
EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas.
DuCote TJ, Song X, Naughton KJ, Chen F, Plaugher DR, Childress AR, Edgin AR, Qu X, Liu J, Liu J, Li F, Wong KK, Brainson CF. DuCote TJ, et al. Among authors: brainson cf. bioRxiv [Preprint]. 2023 Jun 8:2023.06.06.543919. doi: 10.1101/2023.06.06.543919. bioRxiv. 2023. PMID: 37333199 Free PMC article. Updated. Preprint.
Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition.
Burikhanov R, Ganguly S, Ellingson S, Sviripa VM, Araujo N, Li S, Venkatraman P, Rao M, Choughule A, Brainson CF, Zhan CG, Spielmann HP, Watt DS, Govindan R, Rangnekar VM. Burikhanov R, et al. Among authors: brainson cf. Am J Cancer Res. 2023 Mar 15;13(3):976-991. eCollection 2023. Am J Cancer Res. 2023. PMID: 37034206 Free PMC article.
Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors.
Chen F, Byrd AL, Liu J, Flight RM, DuCote TJ, Naughton KJ, Song X, Edgin AR, Lukyanchuk A, Dixon DT, Gosser CM, Esoe DP, Jayswal RD, Orkin SH, Moseley HNB, Wang C, Brainson CF. Chen F, et al. Among authors: brainson cf. Nat Commun. 2023 Jan 20;14(1):336. doi: 10.1038/s41467-023-35784-x. Nat Commun. 2023. PMID: 36670102 Free PMC article.
Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate.
Byrd AL, Qu X, Lukyanchuk A, Liu J, Chen F, Naughton KJ, DuCote TJ, Song X, Bowman HC, Zhao Y, Edgin AR, Wang C, Liu J, Brainson CF. Byrd AL, et al. Among authors: brainson cf. Stem Cell Reports. 2023 Jan 10;18(1):289-304. doi: 10.1016/j.stemcr.2022.11.009. Epub 2022 Dec 15. Stem Cell Reports. 2023. PMID: 36525966 Free PMC article.
Cellular Origins of EGFR-Driven Lung Cancer Cells Determine Sensitivity to Therapy.
Chen F, Liu J, Flight RM, Naughton KJ, Lukyanchuk A, Edgin AR, Song X, Zhang H, Wong KK, Moseley HNB, Wang C, Brainson CF. Chen F, et al. Among authors: brainson cf. Adv Sci (Weinh). 2021 Nov;8(22):e2101999. doi: 10.1002/advs.202101999. Epub 2021 Oct 7. Adv Sci (Weinh). 2021. PMID: 34622577 Free PMC article.
19 results